Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Chinese and Western Patent Medicines	249.44M
Chinese and Western Patent Medicines Growth	-27.83%
Chinese Herbal Medicine	49.00M
Chinese Herbal Medicine Growth	-51.43%
Health Food	10.01M
Health Food Growth	-50.33%
Other Business	4.19M
Other Business Growth	-17.26%
Medical Instruments	3.78M
Medical Instruments Growth	-53.44%
Other	34.78M
Other Growth	-12.58%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
China	351.20M
China Growth	-32.41%